Iterum Therapeutics Plc (ITRM): Significant Improvements, Worth Considering
Iterum Therapeutics Plc (NASDAQ:ITRM) concluded the trading at $1.13 on Friday, April 04 with a fall of -3.42% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.17 and 5Y monthly beta